|
End-of-day quote
Shenzhen S.E.
2026-09-04
|
5-day change | 1st Jan Change | ||
| 8.470 CNY | +0.47% |
|
-6.10% | +6.68% |
| 08-25 | Beijing Beilu Pharmaceutical Co., Ltd. Proposes Interim Cash Dividend for 2026 | CI |
| 08-24 | Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 4.93B 734M 631M 594M 543M 1.02B 69.29B 1.02B 7.02B 2.72B 35.55B 2.76B 2.7B 115B | P/E 2024 |
207x | P/E 2025 | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.76B 709M 610M 574M 524M 981M 66.91B 983M 6.78B 2.63B 34.33B 2.66B 2.6B 111B | EV / Sales 2024 |
3.29x | EV / Sales 2025 | 3.57x |
| Free-Float |
56.4% | Yield 2024 |
0.81% | Yield 2025 | - |
| 1 day | +0.47% | ||
| 1 week | -6.10% | ||
| Current month | -2.87% | ||
| 1 month | +5.48% | ||
| 3 months | +6.68% | ||
| 6 months | -16.22% | ||
| Current year | +6.68% |
| 1 week | 8.36 |  | 8.95 |
| 1 month | 7.9 | | 10.72 |
| Current year | 7.08 | | 11.38 |
| 1 year | 7.08 | | 11.38 |
| 3 years | 3.58 | | 11.98 |
| 5 years | 3.58 | | 11.98 |
| 10 years | 3.58 | | 14.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xu Wang
CEO | Chief Executive Officer | 42 | 2017-12-10 |
Ni Zeng
DFI | Director of Finance/CFO | 34 | 2019-07-31 |
Sen Li
COO | Chief Operating Officer | 45 | 2022-08-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Wang
CHM | Chairman | 42 | 2019-07-31 |
Ying Yang
CHM | Chairman | 48 | 2019-03-20 |
Ze Hui Shao
BRD | Director/Board Member | 46 | 2019-03-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.47% | -6.10% | -18.24% | +33.39% | 734M | |
| -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | |
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | |
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | |
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | |
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | |
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | |
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | |
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | |
| Average | -0.79% | +0.70% | +23.96% | +50.44% | 367.91B | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.62% | +67.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 984M 147M 126M 119M 108M 203M 13.83B 203M 1.4B 544M 7.1B 550M 538M 22.86B | 1.21B 180M 154M 145M 133M 248M 16.95B 249M 1.72B 666M 8.7B 674M 659M 28.02B |
| Net income | 13.65M 2.03M 1.75M 1.65M 1.5M 2.81M 192M 2.82M 19.45M 7.55M 98.5M 7.64M 7.47M 317M | 92.73M 13.81M 11.89M 11.18M 10.22M 19.11M 1.3B 19.16M 132M 51.28M 669M 51.87M 50.74M 2.16B |
| Net Debt | 189M 28.16M 24.24M 22.8M 20.83M 38.97M 2.66B 39.07M 269M 105M 1.36B 106M 103M 4.4B | -169M -25.14M -21.64M -20.36M -18.6M -34.79M -2.37B -34.88M -241M -93.35M -1.22B -94.42M -92.36M -3.92B |
Employees
1,188
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | CN¥8.470 | +0.47% | 25,754,897 |
| 26-09-03 | CN¥8.430 | -1.98% | 24,662,175 |
| 26-09-02 | CN¥8.600 | -1.83% | 26,998,992 |
| 26-09-01 | CN¥8.760 | +0.46% | 32,248,025 |
| 26-08-31 | CN¥8.720 | -3.33% | 36,201,250 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300016 Stock
Select your edition
All financial news and data tailored to specific country editions
